Related Experiment Videos
Tracking the errant cell after the atomic bombings: what went wrong?
1Roy E. Coats Research Laboratories, Department of Radiation Oncology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Box 951714, Los Angeles, CA 90095-1714, USA. kiwamoto@radonc.ucla.edu
Health Physics
|July 11, 2003
Summary
Radiation exposure from atomic bombs linked to liver cancer. Molecular analysis of survivor tumors revealed distinct p53 and M6P/IGF2r gene mutation patterns, suggesting independent cancer development pathways.
Area of Science:
- Molecular biology
- Cancer research
- Radiation oncology
Background:
- Epidemiological data from Hiroshima and Nagasaki atomic bomb survivors link radiation exposure to cancer.
- This data is crucial for assessing radiation-induced cancer risks.
- Understanding the molecular mechanisms of radiation carcinogenesis is essential.
Purpose of the Study:
- To investigate the molecular basis of radiation-induced hepatocellular carcinoma (HCC).
- To analyze mutations in tumor suppressor genes p53 and M6P/IGF2r in HCC tissues from atomic bomb survivors.
Main Methods:
- Retrospective molecular analysis of archival hepatocellular carcinoma tissues.
- Examination of mutations in the p53 and M6P/IGF2r tumor suppressor genes.
Main Results:
- Hepatocellular carcinoma (HCC) cases exhibited mutations in either p53 or M6P/IGF2r, but rarely both.
- The frequency of M6P/IGF2r mutations decreased with increasing radiation dose.
- Conversely, the frequency of p53 mutations increased with radiation dose.
Conclusions:
- Radiation-induced HCC involves at least two independent molecular selection processes.
- The spectrum of molecular alterations in radiation-induced HCC differs from non-radiation-induced (background) tumors.
- This study provides insights into the distinct molecular pathways of radiation carcinogenesis.